Antigenics’ Oncophage Cancer Vaccine Enters Phase II Glioma Study
Brain cancer trial co-sponsored by NCI follows Phase I/II investigator-sponsored study in which a tumor-specific immune response was detected in all 12 patients.
Brain cancer trial co-sponsored by NCI follows Phase I/II investigator-sponsored study in which a tumor-specific immune response was detected in all 12 patients.